Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/jcpt.13199 http://scihub22266oqcxt.onion/10.1111/jcpt.13199 32524645!7307068!32524645     free     free     free Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 249.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 249.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Clin+Pharm+Ther 2020 ; 45 (5): 1199-1205 Nephropedia Template TP {{tp|p=32524645|t=2020. Practice considerations on the use of investigational anti-COVID-19 medications: Dosage, administration and monitoring |pdf=|usr=}}{{32524645}} gab.com Text Practice considerations on the use of investigational anti-COVID-19 medications: Dosage, administration and monitoring JO: J Clin Pharm Ther http://www.kidney.de/pget.php?&tw=1&pmid=32524645 #FOAvip WHAT IS KNOWN AND OBJECTIVE: Understanding investigational medications is important. Many older drugs are being investigated for repurposing against COVID-19. We comment on various drugs currently undergoing such trials to optimize their safe use. COMMENT: We describe medications used during early COVID-19 outbreaks in South Korea, focusing on practice aspects including the method of drug administration, drug formulation, patient-monitoring for adverse reactions and drug interactions informed by our experience during the 2015 outbreak of Middle East respiratory syndrome (MERS). We comment on hydroxychloroquine, chloroquine, lopinavir/ritonavir with zinc supplement, remdesivir, tocilizumab, ciclesonide, niclosamide and high-dose intravenous immunoglobulin (IVIG). WHAT IS NEW AND CONCLUSION: Effective therapies are urgently needed to manage COVID-19, and existing drugs such as antivirals and antimalarials are under investigation for repurposing to meet this need. This process requires up-to-date drug information to ensure optimum use, particularly safety and efficacy profiles of the medications, until convincing evidence is reported. Twit Text FOAVip Practice considerations on the use of investigational anti-COVID-19 medications: Dosage, administration and monitoring ????J Clin Pharm Ther http://www.kidney.de/pget.php?&tw=1&pmid=32524645 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32524645 #FOAvip English Wikipedia <ref>{{Cite pmid|32524645}}</ref> Practice considerations on the use of investigational anti-COVID-19 medications: Dosage, administration and monitoring #MMPMID32524645 Kang JE; Rhie SJ J Clin Pharm Ther 2020[Oct]; 45 (5): 1199-1205 PMID32524645show ga WHAT IS KNOWN AND OBJECTIVE: Understanding investigational medications is important. Many older drugs are being investigated for repurposing against COVID-19. We comment on various drugs currently undergoing such trials to optimize their safe use. COMMENT: We describe medications used during early COVID-19 outbreaks in South Korea, focusing on practice aspects including the method of drug administration, drug formulation, patient-monitoring for adverse reactions and drug interactions informed by our experience during the 2015 outbreak of Middle East respiratory syndrome (MERS). We comment on hydroxychloroquine, chloroquine, lopinavir/ritonavir with zinc supplement, remdesivir, tocilizumab, ciclesonide, niclosamide and high-dose intravenous immunoglobulin (IVIG). WHAT IS NEW AND CONCLUSION: Effective therapies are urgently needed to manage COVID-19, and existing drugs such as antivirals and antimalarials are under investigation for repurposing to meet this need. This process requires up-to-date drug information to ensure optimum use, particularly safety and efficacy profiles of the medications, until convincing evidence is reported. |*COVID-19 Drug Treatment[MESH] |Antimalarials/administration & dosage/adverse effects/therapeutic use[MESH] |Antiviral Agents/administration & dosage/adverse effects/therapeutic use[MESH] |Dose-Response Relationship, Drug[MESH] |Drug Monitoring[MESH] |Drug Repositioning[MESH] |Drugs, Investigational/administration & dosage/adverse effects/*therapeutic use[MESH] |Humans[MESH]Practice considerations on the use of investigational anti-COVID-19 me(epmc).pdf DeepDyve Pubget Overpricing